1、 ZHOU J,TRYGGESTAD E,WEN Z,et al.Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides[J].Nat Med,2011,17(1):130-134. ZHOU J,TRYGGESTAD E,WEN Z,et al.Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides[J].Nat Med,2011,17(1):130-134.
2、 SAGIYAMA K,MASHIMO T,TOGAO O,et al.In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma[J].Proc Natl Acad Sci U S A,2014,111(12):4542-4547. SAGIYAMA K,MASHIMO T,TOGAO O,et al.In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma[J].Proc Natl Acad Sci U S A,2014,111(12):4542-4547.
3、 JIANG Y,YOU K,QIU X,et al.Tumor volume predicts local recurrence in early rectal cancer treated with radical resection:A retrospective observational study of 270 patients[J].Int J Surg,2018(49):68-73. JIANG Y,YOU K,QIU X,et al.Tumor volume predicts local recurrence in early rectal cancer treated with radical resection:A retrospective observational study of 270 patients[J].Int J Surg,2018(49):68-73.
4、 BENSON A B 3rd,BEKAII-SAAB T,CHAN E,et al.Rectal cancer[J].J Natl Compr Canc Netw,2012,10(12):1528-1564. BENSON A B 3rd,BEKAII-SAAB T,CHAN E,et al.Rectal cancer[J].J Natl Compr Canc Netw,2012,10(12):1528-1564.
5、 COMBER H,SHARP L,de CAMARGO CANCELA M,et al.Causes and outcomes of emergency presentation of rectal cancer[J].Int J Cancer,2016,139(5):1031-1039. COMBER H,SHARP L,de CAMARGO CANCELA M,et al.Causes and outcomes of emergency presentation of rectal cancer[J].Int J Cancer,2016,139(5):1031-1039.
6、 KIM S H,YOON J H,LEE Y.Added value of morphologic characteristics on diffusion-weighted images for characterizing lymph nodes in primary rectal cancer[J].Clin Imaging,2015,39(6):1046-1051. KIM S H,YOON J H,LEE Y.Added value of morphologic characteristics on diffusion-weighted images for characterizing lymph nodes in primary rectal cancer[J].Clin Imaging,2015,39(6):1046-1051.
7、 ZHANG X Y,WANG S,LI X T,et al.MRI of extramural venous invasion in locally advanced rectal cancer:Relationship to tumor recurrence and overall survival[J].Radiology,2018,289(3):677-685. ZHANG X Y,WANG S,LI X T,et al.MRI of extramural venous invasion in locally advanced rectal cancer:Relationship to tumor recurrence and overall survival[J].Radiology,2018,289(3):677-685.
8、 ZHAO Q,WAN L,ZOU S,et al.Prognostic risk factors and survival models for T3 locally advanced rectal cancer:What can we learn from the baseline MRI?[J].Eur Radiol,2021,31(7):4739-4750. ZHAO Q,WAN L,ZOU S,et al.Prognostic risk factors and survival models for T3 locally advanced rectal cancer:What can we learn from the baseline MRI?[J].Eur Radiol,2021,31(7):4739-4750.
9、 YEO D M,OH S N,LEE M A,et al.The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data[J].Eur Radiol,2021,31(11):8586-8596. YEO D M,OH S N,LEE M A,et al.The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data[J].Eur Radiol,2021,31(11):8586-8596.
10、 di MAGLIANO M P,LOGSDON C D.Roles for KRAS in pancreatic tumor development and progression[J].Gastroenterology,2013,144(6):1220-1229. di MAGLIANO M P,LOGSDON C D.Roles for KRAS in pancreatic tumor development and progression[J].Gastroenterology,2013,144(6):1220-1229.
11、 SHANG A,GU C,ZHOU C,et al.Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression[J].Cell Commun Signal,2020,18(1):52. SHANG A,GU C,ZHOU C,et al.Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression[J].Cell Commun Signal,2020,18(1):52.
12、 YANG Q,HUO S,SUI Y,et al.Mutation status and immunohistochemical correlation of KRAS,NRAS,and BRAF in 260 Chinese Colorectal and Gastric Cancers.[J].Front Oncol,2018(8):487. YANG Q,HUO S,SUI Y,et al.Mutation status and immunohistochemical correlation of KRAS,NRAS,and BRAF in 260 Chinese Colorectal and Gastric Cancers.[J].Front Oncol,2018(8):487.
13、 BUM-ERDENE K,GHOZAYEL M K,XU D,et al.Covalent fragment screening identifies Rgl2 RalGEF cysteine for targeted covalent inhibition of Ral GTPase activation.[J].Chem Med Chem,2022,17(6):e202100750. BUM-ERDENE K,GHOZAYEL M K,XU D,et al.Covalent fragment screening identifies Rgl2 RalGEF cysteine for targeted covalent inhibition of Ral GTPase activation.[J].Chem Med Chem,2022,17(6):e202100750.
14、 SU C,LIU C,ZHAO L,et al.Amide proton transfer imaging allows detection of glioma grades and tumor proliferation:Comparison with Ki-67 expression and proton MR spectroscopy imaging[J].AJNR Am J Neuroradiol,2017,38(9):1702-1709. SU C,LIU C,ZHAO L,et al.Amide proton transfer imaging allows detection of glioma grades and tumor proliferation:Comparison with Ki-67 expression and proton MR spectroscopy imaging[J].AJNR Am J Neuroradiol,2017,38(9):1702-1709.
15、 MASON B R,CHATTERJEE D,MENIAS C O,et al.Encyclopedia of endometriosis:A pictorial rad-path review[J].Abdom Radiol(NY),2020,45(6):1587-1607. MASON B R,CHATTERJEE D,MENIAS C O,et al.Encyclopedia of endometriosis:A pictorial rad-path review[J].Abdom Radiol(NY),2020,45(6):1587-1607.
16、 BAZOT M,KERMARREC E,BENDIFALLAH S,et al.MRI of intestinal endometriosis[J].Best Pract Res Clin Obstet Gynaecol,2021(71):51-63. BAZOT M,KERMARREC E,BENDIFALLAH S,et al.MRI of intestinal endometriosis[J].Best Pract Res Clin Obstet Gynaecol,2021(71):51-63.
17、 YEMELYANOVA A,VANG R,KSHIRSAGAR M,et al.Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma:An immunohistochemical and nucleotide sequencing analysis[J].Mod Pathol,Inc,2011,24(9):1248-1253. YEMELYANOVA A,VANG R,KSHIRSAGAR M,et al.Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma:An immunohistochemical and nucleotide sequencing analysis[J].Mod Pathol,Inc,2011,24(9):1248-1253.
18、 WANG P,LIANG J,WANG Z,et al.The prognostic value of p53 positive in colorectal cancer:A retrospective cohort study[J].Tumor Biol,2017,39(5):1010428317703651. WANG P,LIANG J,WANG Z,et al.The prognostic value of p53 positive in colorectal cancer:A retrospective cohort study[J].Tumor Biol,2017,39(5):1010428317703651.
19、 Milot L.Amide Proton transfer-weighted MRI:Insight into cancer cell biology[J].Radiology,2022,305(1):135-136. Milot L.Amide Proton transfer-weighted MRI:Insight into cancer cell biology[J].Radiology,2022,305(1):135-136.
20、 ZHOU J,ZHU H,LIM M,et al.Three-dimensional amide proton transfer MR imaging of gliomas:Initial experience and comparison with gadolinium enhancement[J].J Magn Reson Imaging,2013,38(5):1119-1128. ZHOU J,ZHU H,LIM M,et al.Three-dimensional amide proton transfer MR imaging of gliomas:Initial experience and comparison with gadolinium enhancement[J].J Magn Reson Imaging,2013,38(5):1119-1128.
21、 WILKINSON N.Management of rectal cancer[J].Surg Clin North Am,2020,100(3):615-628. WILKINSON N.Management of rectal cancer[J].Surg Clin North Am,2020,100(3):615-628.
22、 WANG S,TRYGGESTAD E,ZHOU T,et al.Assessment of MRI parameters as imaging biomarkers for radiation necrosis in the rat brain[J].Int J Radiat Oncol Biol Phys,2012,83(3):e431-e436. WANG S,TRYGGESTAD E,ZHOU T,et al.Assessment of MRI parameters as imaging biomarkers for radiation necrosis in the rat brain[J].Int J Radiat Oncol Biol Phys,2012,83(3):e431-e436.
23、 ZHOU J,HEO H Y,KNUTSSON L,et al.APT-weighted MRI:Techniques,current neuro applications,and challenging issues[J].J Magn Reson Imaging,2019,50(2):347-364. ZHOU J,HEO H Y,KNUTSSON L,et al.APT-weighted MRI:Techniques,current neuro applications,and challenging issues[J].J Magn Reson Imaging,2019,50(2):347-364.
24、 柳忠美,王文娜.577例直肠癌病理与临床预后关系的研究[J].华南国防医学杂志,2001,15(2):5-6. 柳忠美,王文娜.577例直肠癌病理与临床预后关系的研究[J].华南国防医学杂志,2001,15(2):5-6.
25、 REYNOLDS I S,O’CONNELL E,FICHTNER M,et al.Mucinous adenocarcinoma of the colon and rectum:A genomic analysis[J].J Surg Oncol,2019,120(8):1427-1435. REYNOLDS I S,O’CONNELL E,FICHTNER M,et al.Mucinous adenocarcinoma of the colon and rectum:A genomic analysis[J].J Surg Oncol,2019,120(8):1427-1435.
26、 WONG M C S,HUANG J,LOK V,et al.Differences in incidence and mortality trends of colorectal cancer worldwide based on sex,age,and anatomic location[J].Clin Gastroenterol Hepatol,2021,19(5):955-966.e61. WONG M C S,HUANG J,LOK V,et al.Differences in incidence and mortality trends of colorectal cancer worldwide based on sex,age,and anatomic location[J].Clin Gastroenterol Hepatol,2021,19(5):955-966.e61.
27、 SIEGEL R L,MILLER K D,GODING SAUER A,et al.Colorectal cancer statistics,2020.[J].CA Cancer J Clin,2020,70(3):145-164. SIEGEL R L,MILLER K D,GODING SAUER A,et al.Colorectal cancer statistics,2020.[J].CA Cancer J Clin,2020,70(3):145-164.
28、 HU Y,LI J,ZHUANG Z,et al.Automatic treatment outcome prediction with DeepInteg based on multimodal radiological images in rectal cancer[J].Heliyon,2023,9(2):e13094. HU Y,LI J,ZHUANG Z,et al.Automatic treatment outcome prediction with DeepInteg based on multimodal radiological images in rectal cancer[J].Heliyon,2023,9(2):e13094.
29、 RIESCO-MARTINEZ M C,FERNANDEZ-MARTOS C,GRAVALOS-CASTRO C,et al.Impact of total neoadjuvant therapy vs.standard chemoradiotherapy in locally advanced rectal cancer:A systematic review and meta-analysis of randomized trials[J].Cancers,2020,12(12):3655. RIESCO-MARTINEZ M C,FERNANDEZ-MARTOS C,GRAVALOS-CASTRO C,et al.Impact of total neoadjuvant therapy vs.standard chemoradiotherapy in locally advanced rectal cancer:A systematic review and meta-analysis of randomized trials[J].Cancers,2020,12(12):3655.
30、 QADERI S M,DICKMAN P W,de WILT J H W,et al.Conditional survival and cure of patients with colon or rectal cancer:A population-based study[J].J Natl Compr Canc Netw,2020,18(9):1230-1237. QADERI S M,DICKMAN P W,de WILT J H W,et al.Conditional survival and cure of patients with colon or rectal cancer:A population-based study[J].J Natl Compr Canc Netw,2020,18(9):1230-1237.
31、 丘清. 酰胺质子转移及动态对比增强磁共振成像预测直肠癌KRAS基因突变的研究[D].广州:南方医科大学,2021. 丘清. 酰胺质子转移及动态对比增强磁共振成像预测直肠癌KRAS基因突变的研究[D].广州:南方医科大学,2021.
32、 LI L,CHEN W,YAN Z,et al.Comparative analysis of amide proton transfer MRI and diffusion-weighted imaging in assessing p53 and Ki-67 expression of rectal adenocarcinoma[J].J Magn Reson Imaging,2020,52(5):1487-1496. LI L,CHEN W,YAN Z,et al.Comparative analysis of amide proton transfer MRI and diffusion-weighted imaging in assessing p53 and Ki-67 expression of rectal adenocarcinoma[J].J Magn Reson Imaging,2020,52(5):1487-1496.
33、 李娟,高雪梅,程敬亮.APT定量参数与直肠癌病理类型及分期的相关性[J].放射学实践,2022,37(11):1405-1409. 李娟,高雪梅,程敬亮.APT定量参数与直肠癌病理类型及分期的相关性[J].放射学实践,2022,37(11):1405-1409.
34、 CHEN W,LI L,YAN Z,et al.Three-dimension amide proton transfer MRI of rectal adenocarcinoma:correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging[J].Eur Radiol,2020,31(5):3286-3296. CHEN W,LI L,YAN Z,et al.Three-dimension amide proton transfer MRI of rectal adenocarcinoma:correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging[J].Eur Radiol,2020,31(5):3286-3296.
35、 董宛,陈安良,刘爱连,等.初探酰胺质子转移加权和T2 mapping对直肠癌化疗和未化疗的定量对比研究[J].磁共振成像,2021,12(7):24-28. 董宛,陈安良,刘爱连,等.初探酰胺质子转移加权和T2 mapping对直肠癌化疗和未化疗的定量对比研究[J].磁共振成像,2021,12(7):24-28.
36、 董宛,刘爱连,陈安良,等.酰胺质子转移加权和扩散峰度成像对直肠癌化疗和未化疗的定量对比研究[J].中国医学影像学杂志,2022,30(1):54-59. 董宛,刘爱连,陈安良,等.酰胺质子转移加权和扩散峰度成像对直肠癌化疗和未化疗的定量对比研究[J].中国医学影像学杂志,2022,30(1):54-59.
37、 CHEN W,MAO L,LI L,et al.Predicting treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer using amide proton transfer MRI combined with diffusion-weighted imaging[J].Front Oncol,2021(11):698427. CHEN W,MAO L,LI L,et al.Predicting treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer using amide proton transfer MRI combined with diffusion-weighted imaging[J].Front Oncol,2021(11):698427.
38、 NISHIE A,ASAYAMA Y,ISHIGAMI K,et al.Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer[J].J Gastroenterol Hepatol,2018,34(1):140-146. NISHIE A,ASAYAMA Y,ISHIGAMI K,et al.Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer[J].J Gastroenterol Hepatol,2018,34(1):140-146.
39、 WEI Q,YUAN W,JIA Z,et al.Preoperative MR radiomics based on high-resolution T2-weighted images and amide proton transfer-weighted imaging for predicting lymph node metastasis in rectal adenocarcinoma[J].Abdom Radiol(NY),2023,48(2):458-470. WEI Q,YUAN W,JIA Z,et al.Preoperative MR radiomics based on high-resolution T2-weighted images and amide proton transfer-weighted imaging for predicting lymph node metastasis in rectal adenocarcinoma[J].Abdom Radiol(NY),2023,48(2):458-470.
40、 CHEN W,LIU G,CHEN J,et al.Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma:A preliminary study[J].Eur Radiol,2023. CHEN W,LIU G,CHEN J,et al.Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma:A preliminary study[J].Eur Radiol,2023.
41、 NISHIE A,TAKAYAMA Y,ASAYAMA Y,et al.Amide proton transfer imaging can predict tumor grade in rectal cancer[J].Magn Reson Imaging,2018(51):96-103. NISHIE A,TAKAYAMA Y,ASAYAMA Y,et al.Amide proton transfer imaging can predict tumor grade in rectal cancer[J].Magn Reson Imaging,2018(51):96-103.
42、 LI J,LIN L,GAO X,et al.Amide proton transfer weighted and intravoxel incoherent motion imaging in evaluation of prognostic factors for rectal adenocarcinoma[J].Front Oncol,2022,11:783544. LI J,LIN L,GAO X,et al.Amide proton transfer weighted and intravoxel incoherent motion imaging in evaluation of prognostic factors for rectal adenocarcinoma[J].Front Oncol,2022,11:783544.
43、 OHNO Y,KISHIDA Y,SEKI S,et al.Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions:Comparison with diffusion-weighted imaging and FDG-PET/CT[J].J Magn Reson Imaging,2018,47(4):1013-1021. OHNO Y,KISHIDA Y,SEKI S,et al.Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions:Comparison with diffusion-weighted imaging and FDG-PET/CT[J].J Magn Reson Imaging,2018,47(4):1013-1021.
44、 HE Y L,LI Y,LIN C Y,et al.Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer:A preliminary study.[J].J Magn Reson Imaging,2019,50(4):1318-1325. HE Y L,LI Y,LIN C Y,et al.Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer:A preliminary study.[J].J Magn Reson Imaging,2019,50(4):1318-1325.
45、 YIN H,WANG D,YAN R,et al.Comparison of diffusion kurtosis imaging and amide proton transfer imaging in the diagnosis and risk assessment of prostate cancer[J].Front Oncol,2021(11):640906. YIN H,WANG D,YAN R,et al.Comparison of diffusion kurtosis imaging and amide proton transfer imaging in the diagnosis and risk assessment of prostate cancer[J].Front Oncol,2021(11):640906.
46、 LI Y,LIN C Y,QI Y F,et al.Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma:Correlation with Ki-67 proliferation status[J].Magn Reson Imaging,2021(78):18-24. LI Y,LIN C Y,QI Y F,et al.Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion MR imaging for type I endometrial carcinoma:Correlation with Ki-67 proliferation status[J].Magn Reson Imaging,2021(78):18-24.
47、 MENG N,FANG T,FENG P,et al.Amide proton transfer-weighted imaging and multiple models diffusion-weighted imaging facilitates preoperative risk stratification of early-stage endometrial carcinoma[J].J Magn Reson Imaging,2021,54(4):1200-1211. MENG N,FANG T,FENG P,et al.Amide proton transfer-weighted imaging and multiple models diffusion-weighted imaging facilitates preoperative risk stratification of early-stage endometrial carcinoma[J].J Magn Reson Imaging,2021,54(4):1200-1211.
48、 JIN X,YAN R,LI Z,et al.Evaluation of amide proton transfer-weighted imaging for risk factors in stage I endometrial cancer:A comparison with diffusion-weighted imaging and diffusion kurtosis imaging[J].Front Oncoly,2022(12):876120. JIN X,YAN R,LI Z,et al.Evaluation of amide proton transfer-weighted imaging for risk factors in stage I endometrial cancer:A comparison with diffusion-weighted imaging and diffusion kurtosis imaging[J].Front Oncoly,2022(12):876120.
49、 SHETH V R.Editorial for “Amide proton transfer-weighted imaging combined with intravoxel incoherent motion for evaluating microsatellite instability in endometrial cancer”[J].J Magn Reson Imaging,2022,57(2):506-507. SHETH V R.Editorial for “Amide proton transfer-weighted imaging combined with intravoxel incoherent motion for evaluating microsatellite instability in endometrial cancer”[J].J Magn Reson Imaging,2022,57(2):506-507.
50、 MENG N,FU F,SUN J,et al.Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer:A comparative study with intravoxel incoherent motion and 18F-FDG PET[J].Quant Imaging Med Surg,2022,12(9):4474-4487. MENG N,FU F,SUN J,et al.Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer:A comparative study with intravoxel incoherent motion and 18F-FDG PET[J].Quant Imaging Med Surg,2022,12(9):4474-4487.
51、 KIDO A,TAMADA T,UEDA Y,et al.Comparison between amide proton transfer magnetic resonance imaging using 3-dimensional acquisition and diffusion-weighted imaging for characterization of prostate cancer:A preliminary study[J].J Comput Assist Tomogr,2023,47(2):178-185. KIDO A,TAMADA T,UEDA Y,et al.Comparison between amide proton transfer magnetic resonance imaging using 3-dimensional acquisition and diffusion-weighted imaging for characterization of prostate cancer:A preliminary study[J].J Comput Assist Tomogr,2023,47(2):178-185.
52、 Z?LLNER H J,BUTZ M,J?RDENS M,et al.Chemical exchange saturation transfer imaging in hepatic encephalopathy[J].Neuroimage Clin,2019(22):101743. Z?LLNER H J,BUTZ M,J?RDENS M,et al.Chemical exchange saturation transfer imaging in hepatic encephalopathy[J].Neuroimage Clin,2019(22):101743.
53、 YU H,WEN X,WU P,et al.Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?[J].Eur Radiol,2019,29(10):5298-5306. YU H,WEN X,WU P,et al.Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?[J].Eur Radiol,2019,29(10):5298-5306.
54、 YU H,ZHU L,WANG Y,et al.Amide proton transfer weighted MR imaging for predicting meningioma stiffness:A feasibility study[J].J Magn Reson Imaging,2022,57(4):1071-1078. YU H,ZHU L,WANG Y,et al.Amide proton transfer weighted MR imaging for predicting meningioma stiffness:A feasibility study[J].J Magn Reson Imaging,2022,57(4):1071-1078.
55、 KOIKE H,MORIKAWA M,ISHIMARU H,et al.Quantitative chemical exchange saturation transfer imaging of amide proton transfer differentiates between cerebellopontine angle schwannoma and meningioma:Preliminary results[J].Int J Mol Sci,2022,23(17):10187. KOIKE H,MORIKAWA M,ISHIMARU H,et al.Quantitative chemical exchange saturation transfer imaging of amide proton transfer differentiates between cerebellopontine angle schwannoma and meningioma:Preliminary results[J].Int J Mol Sci,2022,23(17):10187.
56、 FRIISMOSE A I,MARKOVIC L,NGUYEN N,et al.Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T[J].Radiography,2021,28(1):95-101. FRIISMOSE A I,MARKOVIC L,NGUYEN N,et al.Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T[J].Radiography,2021,28(1):95-101.
57、 ZHANG H W,LIU X L,ZHANG H B,et al.Differentiation of meningiomas and gliomas by amide proton transfer imaging:A preliminary study of brain tumour infiltration[J].Front Oncol,2022(12):886968. ZHANG H W,LIU X L,ZHANG H B,et al.Differentiation of meningiomas and gliomas by amide proton transfer imaging:A preliminary study of brain tumour infiltration[J].Front Oncol,2022(12):886968.
58、 SU C,JIANG J,LIU C,et al.Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities:A histogram analysis.[J].Neuroradiology,2021,63(5):685-693. SU C,JIANG J,LIU C,et al.Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities:A histogram analysis.[J].Neuroradiology,2021,63(5):685-693.
59、 VINOGRADOV E,SHERRY A D,LENKINSKI R E.CEST:From basic principles to applications,challenges and opportunities[J].J Magn Reson,2013(229):155-72. VINOGRADOV E,SHERRY A D,LENKINSKI R E.CEST:From basic principles to applications,challenges and opportunities[J].J Magn Reson,2013(229):155-72.
60、 HOBBS S K,SHI G,HOMER R,et al.Magnetic resonance image-guided proteomics of human glioblastoma multiforme[J].J Magn Reson Imaging,2003,18(5):530-536. HOBBS S K,SHI G,HOMER R,et al.Magnetic resonance image-guided proteomics of human glioblastoma multiforme[J].J Magn Reson Imaging,2003,18(5):530-536.
61、 SUN P Z,XIAO G,ZHOU I Y,et al.A method for accurate pH mapping with chemical exchange saturation transfer(CEST)MRI[J].Contrast Media Mol Imaging,2016,11(3):195-202. SUN P Z,XIAO G,ZHOU I Y,et al.A method for accurate pH mapping with chemical exchange saturation transfer(CEST)MRI[J].Contrast Media Mol Imaging,2016,11(3):195-202.
62、 van ZIJL P C,ZHOU J,MORI N,et al.Mechanism of magnetization transfer during on-resonance water saturation.A new approach to detect mobile proteins,peptides,and lipids[J].Magn Reson Med,2003,49(3):440-449. van ZIJL P C,ZHOU J,MORI N,et al.Mechanism of magnetization transfer during on-resonance water saturation.A new approach to detect mobile proteins,peptides,and lipids[J].Magn Reson Med,2003,49(3):440-449.
63、 JOKIVARSI K T,GR?HN H I,GR?HN O H,et al.Proton transfer ratio,lactate,and intracellular pH in acute cerebral ischemia[J].Magn Reson Med,2007,57(4):647-653. JOKIVARSI K T,GR?HN H I,GR?HN O H,et al.Proton transfer ratio,lactate,and intracellular pH in acute cerebral ischemia[J].Magn Reson Med,2007,57(4):647-653.
64、 KAMIMURA K,NAKAJO M,YONEYAMA T,et al.Amide proton transfer imaging of tumors:Theory,clinical applications,pitfalls,and future directions[J].Jpn J Radiol,2018,37(2):109-116. KAMIMURA K,NAKAJO M,YONEYAMA T,et al.Amide proton transfer imaging of tumors:Theory,clinical applications,pitfalls,and future directions[J].Jpn J Radiol,2018,37(2):109-116.
65、 WARD K M,ALETRAS A H,BALABAN R S.A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer(CEST)[J].J Magn Reson,2000,143(1):79-87. WARD K M,ALETRAS A H,BALABAN R S.A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer(CEST)[J].J Magn Reson,2000,143(1):79-87.
66、 ZHOU J,PAYEN J F,WILSON D A,et al.Using the amide proton signals of intra-cellular proteins and peptides to detect pH effects in MRI[J].Nat Med,2003,9(8):1085-1090. ZHOU J,PAYEN J F,WILSON D A,et al.Using the amide proton signals of intra-cellular proteins and peptides to detect pH effects in MRI[J].Nat Med,2003,9(8):1085-1090.
67、 ZHOU Y,YANG R,WANG Y,et al.Histogram analysis of diffusion-weighted magnetic resonance imaging as a biomarker to predict LNM in T3 stage rectal carcinoma[J].BMC Med Imaging,2021,21(1):176. ZHOU Y,YANG R,WANG Y,et al.Histogram analysis of diffusion-weighted magnetic resonance imaging as a biomarker to predict LNM in T3 stage rectal carcinoma[J].BMC Med Imaging,2021,21(1):176.
68、 DEL RIO P,LODERER T,BRESCIANI P,et al.MRI and correlation between TNM and CEA,CA19.9,AFP in rectal cancer experience of a single academic surgical center[J].Ann Ital Chir,2021(92):645-653. DEL RIO P,LODERER T,BRESCIANI P,et al.MRI and correlation between TNM and CEA,CA19.9,AFP in rectal cancer experience of a single academic surgical center[J].Ann Ital Chir,2021(92):645-653.
69、 ZHU H,WANG D,XU L,et al.Correction:Diagnostic value of an enhanced MRI combined with serum CEA,CA19-9,CA125 and CA72-4 in the liver metastasis of colorectal cancer[J].World J Surg Oncol,2023,21(1):92. ZHU H,WANG D,XU L,et al.Correction:Diagnostic value of an enhanced MRI combined with serum CEA,CA19-9,CA125 and CA72-4 in the liver metastasis of colorectal cancer[J].World J Surg Oncol,2023,21(1):92.
70、 万珊杉,易晓佳,马逸群,等.直肠癌MRI术前评估价值与术后病理对比研究[J].医学影像学杂志,2022,32(2):292-295. 万珊杉,易晓佳,马逸群,等.直肠癌MRI术前评估价值与术后病理对比研究[J].医学影像学杂志,2022,32(2):292-295.
71、 FERNANDES M C,HORVAT N.Editorial for “A deep learning model based on mri and clinical factors facilitates noninvasive prediction of kras mutation in rectal cancer”[J].J Magn Reson Imaging,2022,56(6):1669-1670. FERNANDES M C,HORVAT N.Editorial for “A deep learning model based on mri and clinical factors facilitates noninvasive prediction of kras mutation in rectal cancer”[J].J Magn Reson Imaging,2022,56(6):1669-1670.
72、 LIU H,YIN H,LI J,et al.A deep learning model based on MRI and clinical factors facilitates noninvasive evaluation of KRAS mutation in rectal cancer[J].J Magn Reson Imaging,2022,56(6):1659-1668. LIU H,YIN H,LI J,et al.A deep learning model based on MRI and clinical factors facilitates noninvasive evaluation of KRAS mutation in rectal cancer[J].J Magn Reson Imaging,2022,56(6):1659-1668.
73、 WANG P P,DENG C L,WU B.Magnetic resonance imaging-based artificial intelligence model in rectal cancer[J].World J Gastroenterol,2021,27(18):2122-2130. WANG P P,DENG C L,WU B.Magnetic resonance imaging-based artificial intelligence model in rectal cancer[J].World J Gastroenterol,2021,27(18):2122-2130.
74、 ORONSKY B,REID T,LARSON C,et al.Locally advanced rectal cancer:The past,present,and future[J].Semin Oncol,2020,47(1):85-92. ORONSKY B,REID T,LARSON C,et al.Locally advanced rectal cancer:The past,present,and future[J].Semin Oncol,2020,47(1):85-92.
75、 贾绚,赖灿,马晓辉.酰胺质子转移成像的临床研究进展[J].中国医疗器械杂志,2020,44(2):185-188. 贾绚,赖灿,马晓辉.酰胺质子转移成像的临床研究进展[J].中国医疗器械杂志,2020,44(2):185-188.
76、 中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志,2018,56(4):241-258. 中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志,2018,56(4):241-258.
77、 鲍淑梅,张亚杰,田丰.炎症性肠病合并结直肠癌的流行病学和防治进展[J].中国临床医生杂志,2021,49(12):1409-1413. 鲍淑梅,张亚杰,田丰.炎症性肠病合并结直肠癌的流行病学和防治进展[J].中国临床医生杂志,2021,49(12):1409-1413.
78、 YANG Y,WANG H Y,CHEN Y K,et al.Current status of surgical treatment of rectal cancer in China[J].Chin Med J(Engl),2020,133(22):2703-2711. YANG Y,WANG H Y,CHEN Y K,et al.Current status of surgical treatment of rectal cancer in China[J].Chin Med J(Engl),2020,133(22):2703-2711.
79、 冯晓源.精准医疗,影像先行[J].中华放射学杂志,2016,50(1):1-2. 冯晓源.精准医疗,影像先行[J].中华放射学杂志,2016,50(1):1-2.
80、 SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30. SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
81、 BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
